Acute Lymphocytic Leukemia (ALL) Completed Phase 1 / 2 Trials for Dexamethasone (DB01234)

Also known as: Lymphocytic Leukemia, Acute / Acute Lymphocytic Leukemia / Acute Lymphoid Leukemia (ALL) / Acute Lymphatic Leukemia / Acute Lymphocytic Leukaemia / Acute Lymphoid Leukemia / Acute lymphoblastic leukemia with failed remission / Acute lymphoblastic leukaemia / Leukemia lymphoblastic acute / Acute lymphoblastic leukemia / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / ALL / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic

IndicationStatusPhase
DBCOND0030518 (Acute Lymphocytic Leukemia (ALL))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02404220Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Treatment
NCT00968253RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic LeukemiaTreatment